BIOMAT Database Logo BIOMAT Database Logo

Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea. 1996

M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri

UI MeSH Term Description Entries
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008297 Male Males
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
August 1999, Haematologica,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
February 1996, American journal of hematology,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
[Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
January 2006, Presse medicale (Paris, France : 1983),
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
[Acute myelogenous leukemia in nonradiation treated polycythemia vera].
October 1975, Ugeskrift for laeger,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Hydroxyurea-associated acral erythema in a patient with polycythemia vera.
September 2014, American journal of hematology,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Hydroxyurea-induced stomatocytes in a patient presenting with polycythemia vera.
June 2015, American journal of hematology,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Myeloid sarcoma developing in prexisting hydroxyurea-induced leg ulcer in a polycythemia vera patient.
January 2013, Case reports in medicine,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea.
April 2018, The Journal of dermatology,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Acute leukemia in polycythemia vera.
January 1976, Seminars in hematology,
M Pulik, and F Lionnet, and P Genet, and C Petitdidier, and L Jary, and T Touahri
Acute leukemia in polycythemia vera.
August 1981, The New England journal of medicine,
Copied contents to your clipboard!